Literature DB >> 18078702

Toxicologic evaluation of modified gum acacia: mutagenicity, acute and subchronic toxicity.

D Schmitt1, N Tran, S Riefler, J Jacoby, D Merkel, P Marone, N Naouli.   

Abstract

Modified gum acacia, produced from acacia gum by a process analogous to the production of modified food starch, was tested for mutagenicity in the microbial reverse mutation assay. The assay employed a wide range of dose levels, both with and without metabolic activation. Test results gave no indication that modified gum acacia possessed any mutagenic potential. The acute oral toxicity of modified gum acacia was determined in two studies employing Sprague-Dawley rats, and the LD50 values were found to be >2000 mg/kg. The primary dermal irritation potential of modified gum acacia was evaluated in rabbits by the Draize method. Test results indicated that modified gum acacia was slightly irritating by the Environmental Protection Agency (EPA) classification but not a primary irritant by Consumer Product Safety Commission (CPSC) guidelines. The subchronic toxicity of modified gum acacia was examined in Sprague-Dawley rats fed diets containing 0%, 1%, 2.5%, and 5% modified gum acacia for 13 weeks. No dose-related effects on survival, growth, hematology, blood chemistry, organ weights, or pathologic lesions were observed. Results of these studies indicate that modified gum acacia does not possess mutagenic potential and that animals are not adversely affected by acute or subchronic exposure to modified gum acacia.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18078702     DOI: 10.1016/j.fct.2007.10.038

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  3 in total

1.  The safety of flavocoxid, a medical food, in the dietary management of knee osteoarthritis.

Authors:  Sarah L Morgan; Joseph E Baggott; Larry Moreland; Renee Desmond; Angela C Kendrach
Journal:  J Med Food       Date:  2009-10       Impact factor: 2.786

2.  Use of seed gums from Tamarindus indica and Cassia fistula as controlled-release agents.

Authors:  Kampanart Huanbutta; Wancheng Sittikijyothin
Journal:  Asian J Pharm Sci       Date:  2018-03-26       Impact factor: 6.598

3.  Biopolymer Extracted from Anadenanthera colubrina (Red Angico Gum) Exerts Therapeutic Potential in Mice: Antidiarrheal Activity and Safety Assessment.

Authors:  Thiago S L Araújo; Taiane M de Oliveira; Nayara A de Sousa; Luan K M Souza; Francisca B M Sousa; Ana P de Oliveira; Lucas A D Nicolau; Alfredo A V da Silva; Alyne R Araújo; Pedro J C Magalhães; Daniel F P Vasconcelos; Hugo R de Jonge; Marcellus H L P Souza; Durcilene A Silva; Regina C M Paula; Jand Venes R Medeiros
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.